Skip to content

Merck & Co. MRK Change in AP

Change in AP at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$409M+581%
Pfizer logo
PfizerPFE
-$117.25M+54.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$3.92B-84.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$107.7M+150%
Cytokinetics logo
CytokineticsCYTK
$1.52M+133%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$2.94M-110%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$317.37B+60.3%
Enterprise value$361.07B+59.3%
P/E35.5×+23.5×
P/S4.8×+1.7×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Merck & Co.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s change in AP?
Merck & Co. (MRK) reported change in AP of $27.5M in Q4 2025.
How has Merck & Co.'s change in AP changed year-over-year?
Merck & Co.'s change in AP decreased by 39.6% year-over-year, from $45.5M to $27.5M.
What is the long-term trend for Merck & Co.'s change in AP?
Over 4 years (2021 to 2025), Merck & Co.'s change in AP has grown at a -27.8% compound annual growth rate (CAGR), from $405M to $110M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.